Singular Genomics Systems, Inc. (OMIC)

NASDAQ: OMIC · IEX Real-Time Price · USD
2.98
-0.23 (-7.03%)
At close: Aug 18, 2022 4:00 PM
2.99
+0.02 (0.50%)
After-hours: Aug 18, 2022 5:42 PM EDT
-7.03%
Market Cap 211.80M
Revenue (ttm) n/a
Net Income (ttm) -83.36M
Shares Out 71.19M
EPS (ttm) 0.07
PE Ratio 42.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 311,312
Open 3.19
Previous Close 3.20
Day's Range 2.87 - 3.19
52-Week Range 2.64 - 18.19
Beta n/a
Analysts Buy
Price Target 5.61 (+88.6%)
Earnings Date Aug 9, 2022

About OMIC

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiom... [Read more...]

Industry Medical Instruments & Supplies
IPO Date May 27, 2021
Employees 248
Stock Exchange NASDAQ
Ticker Symbol OMIC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for OMIC stock is "Buy." The 12-month stock price forecast is 5.61, which is an increase of 88.57% from the latest price.

Price Target
$5.61
(88.57% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researcher...

Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results

SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researcher...

Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit

Fireside chat now scheduled for 8:00am PT on Thursday, August 11, 2022 Fireside chat now scheduled for 8:00am PT on Thursday, August 11, 2022

Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer

The company further expanded its commercial leadership team with the appointment of Jeff Bullard as Head of Sales for North America The company further expanded its commercial leadership team with the a...

Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researcher...

Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher

Similar Genomics Systems (OMIC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions c...

Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

SAN DIEGO, June 03, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researcher...

3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

Our roundtable found three biotechs with a nice cash cushion.

Other symbols: AGENNVTA

Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know

Similar Genomics Systems (OMIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1

Improved patient volumes, a diversified healthcare portfolio and various technological advancements are likely to favor first-quarter results of ELAN, DCGO and OMIC.

Other symbols: DCGOELAN

Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022

LA JOLLA, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and c...

Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results

LA JOLLA, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower re...

Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits

This collaboration integrates G4's accuracy, speed, flexibility and power with the KAPA DNA and RNA Library Prep Kits to empower high-quality, established workflows for customers This collaboration inte...

Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform

This partnership integrates G4's accuracy, speed, flexibility and power with the QIAseq DNA and RNA Library Prep Kits to empower high-quality, established workflows for customers This partnership integr...

6 Underperforming IPO Stocks To Buy On The Dip

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last y...

Other symbols: FDMTFWRGNRDSPRCTVECT

Singular Genomics Partners with New England Biolabs® to Enable NEBNext® Kits for the G4 Sequencing Platform

This partnership integrates G4's accuracy, speed, flexibility and power with the NEBNext DNA and RNA Library Prep Kits to empower high-quality, established workflows for customers This partnership integ...

Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform

This partnership integrates G4's accuracy, speed, flexibility and power with Lexogen's expertise in RNA library preparation kits to empower specialized workflows for customers. This partnership integrat...

Singular Genomics G4 Launch Impresses BofA Analyst: What's Next?

Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter of 2022, according to BofA Secu...

Singular Genomics Systems, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

Management to Discuss the Launch of the G4 Sequencing Platform Management to Discuss the Launch of the G4 Sequencing Platform

Singular Genomics Appoints Genomics Research Pioneer Elaine R. Mardis, Ph.D.

LA JOLLA, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower res...

Singular Genomics and Broad Institute Partner to Integrate Advanced Sequencing Technology with the Terra Data Platform

This partnership will help biomedical researchers access and analyze data from Singular Genomics systems and easily collaborate on the cloud using a secure, scalable and open source informatic platform ...

Singular Genomics Launches the G4 Sequencing Platform

– Next-generation sequencing platform will provide up to three times more data output per hour than other benchtop instruments, while offering flexible run capacity – – Next-generation sequencing platfo...

Singular Genomics Systems, Inc. Reports Recent Highlights and Third Quarter Financial Results

LA JOLLA, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company focused on delivering genomic technologies for the advancement of science and medicine, toda...

Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results on November 9, 2021

LA JOLLA, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced tha...

Singular Genomics Systems, Inc. to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

LA JOLLA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company focused on delivering genomic technologies for the advancement of science and medicine, today announced it ...